Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
Explore innovative Type 2 diabetes drugs that enhance insulin sensitivity and reduce side effects from older treatments.
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...
Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
New mouse studies show a repurposed drug and intranasal insulin improved memory, reduced brain inflammation, and aided ...
As the new year begins, many are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss. While effective, ...
The tobacco industry rebranded a brutally addictive drug from deadly to desirable—and the longer-term health consequences may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback